Manufacturing / Pharmaceutical Preparations
ACADIA PHARMACEUTICALS INC
ACAD
$21.60
-$0.01 (-0.05%)
3.5 B
Market Cap (Mid Cap)
35%
IV Rank
57.0%
Implied Volatility
Aug 04
Next Earnings
Insider Trades
0 buys
26 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| May 04, 2026 | Schneyer Mark C. | Sell | 3,506 | $76,396 | |
| May 04, 2026 | Kihara James | Sell | 1,332 | $29,024 | |
| May 01, 2026 | Schneyer Mark C. | Exercise | 6,815 | $0 | |
| May 01, 2026 | Schneyer Mark C. | Exercise | 6,815 | $0 | |
| May 01, 2026 | Kihara James | Exercise | 2,596 | $0 | |
| May 01, 2026 | Kihara James | Exercise | 2,596 | $0 | |
| Apr 07, 2026 | Schneyer Mark C. | Sell | 2,709 | $60,140 | |
| Apr 07, 2026 | Kihara James | Sell | 1,030 | $22,866 | |
| Apr 05, 2026 | Schneyer Mark C. | Exercise | 5,276 | $0 | |
| Apr 05, 2026 | Schneyer Mark C. | Exercise | 5,276 | $0 |
Politician Trades in ACAD
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Jun 16, 2022 | Chris Jacobs | R | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.06 | $0.02 | -68.4% | Miss |
| Dec 31, 2025 | Q4 2025 | $0.14 | $1.60 | +1044.5% | Beat |
| Sep 30, 2025 | Q3 2025 | $0.15 | $0.42 | +178.1% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.14 | $0.16 | +14.4% | Beat |
| Mar 31, 2025 | Q1 2025 | $0.11 | $0.11 | -3.2% | Miss |
Track ACAD with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ACAD and your entire portfolio.